Binding of the competitive inhibitor L-captopril to the dapEencoded N-succinyl-L,L-diaminopimelic acid desuccinylase from Neisseria meningitidis (NmDapE) was examined by kinetic, spectroscopic, and crystallographic methods. L-Captopril, an angiotensin-converting enzyme (ACE) inhibitor, was previously shown to be a potent inhibitor of the DapE from Haemophilus influenzae (HiDapE) with an IC50 of 3.3 μM and a measured Ki of 1.8 μM and displayed a dose-responsive antibiotic activity toward Escherichia coli. L-Captopril is also a competitive inhibitor of NmDapE with a Ki of 2.8 μM. To examine the nature of the interaction of L-captopril with the dinuclear active site of DapE, we have obtained electron paramagnetic resonance (EPR) and magnetic circular dichroism (MCD) data for the enzymatically hyperactive Co(II)-substituted forms of both HiDapE and NmDapE. EPR and MCD data indicate that the two Co(II) ions in DapE are NOT THE PUBLISHED VERSION; this is the author's final, peer-reviewed manuscript. The published version may be accessed by following the link in the citation at the bottom of the page.
antiferromagnetically coupled, yielding an S = 0 ground state, and suggest a thiolate bridge between the two metal ions. Verification of a thiolate-bridged dinuclear complex was obtained by determining the three-dimensional X-ray crystal structure of NmDapE in complex with L-captopril at 1.8 Å resolution. Combination of these data provides new insights into binding of L-captopril to the active site of DapE enzymes as well as important inhibitor-active site residue interaction's. Such information is critical for the design of new, potent inhibitors of DapE enzymes.
Graphical abstract
Several pathogenic bacteria, some of which were thought to have been eradicated, have made a significant resurgence because of bacterial resistance to antibiotics. 1, 2 According to the Centers for Disease Control and Prevention, several bacterial strains currently exhibit multidrug resistance, with >60% of hospital-acquired infections in the United States caused by the so-called ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species). 3 To alleviate the problem of antibiotic resistance, it is important that new enzymatic targets be identified and specific inhibitors developed. 4 The meso-diaminopimelate (mDAP)/lysine biosynthetic pathway offers several potential antibacterial enzyme targets, such as the dapE-encoded N-succinyl-L,L-diaminopimelic acid desuccinylase (DapE). [5] [6] [7] The products of this pathway, mDAP and lysine, are essential components of the peptidoglycan cell wall for Gram-negative and most Gram-positive bacteria, providing a link between polysaccharide strands. 6, 8, 9 DapE genes have been identified in a large number of pathogenic Gram-positive and Gram-negative bacteria, including all of the ESKAPE pathogens. [10] [11] [12] [13] [14] [15] [16] Sequence alignment of these DapE genes reveals a minimum of 49% sequence identity. Deletion of the gene encoding DapE is lethal to Helicobacter pylori and Mycobacterium smegmatis even in the presence of lysinesupplemented media. 10, 17 Therefore, DapEs are essential for bacterial cell growth and, as there are no similar biosynthetic pathways in mammals, are targets for inhibitors that may possess antimicrobial activity. 5 DapEs are metalloenzymes that catalyze the hydrolysis of Nsuccinyl-L,L-diaminopimelic acid (SDAP), forming L,L-diaminopimelic acid and succinate. 8 DapEs have been purified from multiple sources, but the best characterized example is the DapE from Haemophilus influenzae (HiDapE), which is a homodimeric enzyme (subunit Mr = 41.6 kDa) that requires two Zn(II) ions per mole of polypeptide for full enzymatic activity. 13 The X-ray crystal structures for both mono-and dinuclear Zn(II) forms of HiDapE [Zn_(HiDapE) and ZnZn(HiDapE)] have been reported previously. 16 In the dinuclear Zn(II) form, each Zn(II) ion adopts a distorted tetrahedral geometry coordinated by one imidazole (H67 for Zn1 and H349 for Zn2) and one carboxylate group (E163 for Zn1 and E135 for Zn2). Both Zn(II) ions are bridged by an additional carboxylate group (D100) and a water/hydroxide, forming a (μ-aquo)(μ-carboxylato)dizinc(II) core with a 3.3 Å Zn-Zn distance. 16 To date, no X-ray crystallographic data for a DapE-inhibitor complex have been reported. Thiols are commonly used as inhibitors of Zn(II) metalloproteins because Zn(II) is a relatively soft acid and thiols are soft bases. 18 Examination of several thiol-based compounds led to the identification of moderately strong inhibitors of HiDapE. 14, 19 For example, Lpenicillamine exhibits an IC50 value of 13.7 μM toward HiDapE and is a Biochemistry, Vol 54, No. 31 : pg. 4834-4844. DOI. This article is © American Chemical Society and permission has been granted for this version to appear in e-Publications@Marquette. American Chemical Society does not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission from American Chemical Society.
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competitive inhibitor with a measured Ki of 4.6 μM. DapE is also stereoselective with respect to the recognition of substrate and inhibitors, as D-penicillamine provided an IC50 value of 50 μM. 14 Similarly, L-captopril, an angiotensin-converting enzyme (ACE) inhibitor, exhibited an IC50 value of 3.3 μM toward HiDapE, while Dcaptopril yielded an IC50 value of 42 μM. L-Captopril was shown to be a competitive inhibitor of HiDapE with a measured Ki of 1.8 μM and displayed a dose-responsive antibiotic activity toward Escherichia coli.
14 Even though L-captopril is a moderately tight binding inhibitor of DapE enzymes and is a promising lead compound for the development of a novel class of DapE inhibitors, no information about how Lcaptopril binds to DapE, a requirement for the rational design of new, more potent DapE inhibitors, has been published.
A likely important characteristic of a highly specific, tight binding inhibitor of DapE enzymes will be the molecule's ability to bind to the metal ions in the active site. Several factors are important for interactions of L-captopril with the active site metal ions of DapE, some of which are metal coordination geometry, open metal coordination sites (i.e., those filled by water molecules), and the number of active site metal ions. Therefore, we have analyzed the binding of L-captopril to HiDapE and the DapE from Neisseria meningitidis (NmDapE) via kinetic and spectroscopic methods. We have also determined the X-ray crystal structure of the NmDapE enzyme in complex with L-captopril at 1.8 Å resolution. These data provide insight into interactions of L-captopril with the active site metal ions as well as adjacent active site amino acid residues, providing new insight into the rational design of new, more potent inhibitors of DapE enzymes.
Methods

Materials
D,L-α,ɛ-Diaminopimelic acid (98%), succinic anhydride, and ionexchange resin (Dowex 50WX8-200, H + form) were purchased from Sigma. 2-Naphthalenesulfonic acid 1-hydrate (98%) was purchased from TCI, and microcrystalline cellulose was purchased from Merck. All other chemicals were purchased from commercial sources and were of The HiDapE enzyme was expressed and purified as described previously. 21 The DapE gene from N. meningitidis (NmDapE) was cloned into the pMCSG7 vector using the ligation-independent cloning method. 22 The following primers were used: 5′-TAC TTC CAA TCC AAT GCC GCA GCT GCA GCT GCA AAA GAA AAA GTG GTT TCG TTG GCA CAA G-3′ and 5′-TTA TCC ACT TCC AAT GTT AGT TAG CTA TCC AAT AAA TTC ACT AAC ATT TTG TG-3′. The PCR product was purified using the QIAquick PCR Purification Kit (Qiagen) to remove the primers and dNTPs from the PCR mixture. T4 polymerase was employed to create overhangs on the PCR fragments. The resulting plasmid was transformed into BL21(DE3)/magic E. coli competent cells and grown in Luria-Bertani broth containing ampicillin (150 μg mL −1 ) and kanamycin (25 μg mL −1 ) at 37 °C to an A600 of 1.0 while being shaken. IPTG was added (0.4 mM), and culture growth was continued for 16 h at 18 °C. Cells were recovered by centrifugation (12000g) for 15 min at 4 °C using a Beckman Coulter Avanti J-E Centrifuge. NmDapE was purified according to the standard protocol for Ni-NTA affinity chromatography, and all steps were performed at 4 °C. 23 The His6 tag was removed by treating each enzyme with His6-tagged TEV protease for 16 h at 4 °C in 50 mM HEPES (pH 8.0). Cleaved protein was separated from His6-tagged TEV using Ni-NTA affinity chromatography.
Enzymatic Assay
The specific activity of HiDapE and NmDapE was determined using a 50/50 mixture of D,D-and L,L-SDAP as the substrate in 50 mM phosphate buffer (PPi) (pH 7.5) as previously described. 24 The kinetic parameters Vmax and Km were determined by quantifying amide bond cleavage (decrease in absorbance) of L,L-SDAP at 225 nm (ɛ = 698 M −1 cm −1 ) in triplicate using a Shimadzu UV-2450 spectrophotometer equipped with a temperature controller (25 °C). Enzyme activities are expressed as units per milligram, where 1 unit is defined as the amount of enzyme that releases 1 μmol of L,L-SDAP at 30 °C in 1 min. Catalytic activities were determined with an error of
Inhibition of NmDapE by L-Captopril
The kinetic parameters v (velocity), kcat (Vmax/[E]0), Km (Michaelis constant), and Ki (inhibition constant) were determined in 50 mM phosphate buffer (pH 7.5) spectrophotometrically by recording the initial velocity of the hydrolysis of L,L-SDAP at 25 °C in triplicate.
14 L-Captopril concentrations ranged from 0 to 0.1 mM. The linearity of the progress curves for product formation in the absence and presence of an inhibitor indicated that L-captopril is in rapid equilibrium with NmDapE. The initial rates were plotted against substrate concentration, and the kinetic constants were calculated using Origin software. 20, 24, 25 
Co(II)-Substituted DapE Samples
Apo-DapE was prepared by extensive dialysis for 72 h at 4 °C against 10 mM EDTA in 50 mM HEPES buffer (pH 7.5). DapE was then exhaustively dialyzed against metal-free (Chelex-100 treated) 50 mM HEPES buffer (pH 7.5). Any remaining metal ions were estimated by comparing the activity of the apoenzyme with that of a sample that had been reconstituted with Zn(II). DapE incubated with EDTA typically had <5% residual activity after dialysis. The mono-and dicobalt(II) forms of HiDapE and NmDapE were prepared using apoDapE samples that were incubated with CoCl2 (99.999%; Strem Chemicals, New-buryport, MA) for 30 min at 25 °C prior to exhaustive dialysis into Chelex-100-treated buffer as previously reported. 26 
Electron Paramagnetic Resonance Spectroscopy
Electron paramagnetic resonance (EPR) spectra were recorded at 4.5-35 K and 9.63 GHz (ER4116DM resonator with B0⊥B1), 9.37 GHz (ER4116DM resonator with B0‖B1), or 9.39 GHz (SHQ resonator) using 1.2 mT (12 G) magnetic-field modulation at 100 kHz with phasesensitive detection on a Bruker EleXsys E600 spectrometer equipped with an Oxford Instruments ESR900 helium flow cryostat and ITC503 temperature controller. The SHQ resonator has a B1 for a given Biochemistry, Vol 54, No. 31 (August 11, 2015): pg. 4834-4844. DOI. This article is © American Chemical Society and permission has been granted for this version to appear in e-Publications@Marquette. American Chemical Society does not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission from American Chemical Society.
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microwave power significantly higher than that of the ER4116DM resonator (we estimate by a factor of ~5). Background signals were collected on samples of frozen buffer and subtracted.
Magnetic Circular Dichroism Studies
The magnetic circular dichroism (MCD) instrument consists of a JASCO J815 spectropolarimeter and an Oxford Instruments SM4000 cryostat/magnet. Variable-temperature variable-field (VTVH) MCD data were collected in increments of 0.5 T (T) from 0 to 7.0 T and at temperatures (nominally) of 1.5, 3.0, 6.0, 12, 24, and 48 K. Spectra were collected at a 1.0 nm bandwidth and scanned at 50 nm/min using a time constant of 1 s. The sample cell has a 0.62 cm path length. Each spectrum was corrected for any natural CD by subtracting the zero-field spectrum of the sample. Even when there is no sample present, the instrument baseline exhibits a small deviation from zero that is both field-and wavelength-dependent. Therefore, each spectrum was also corrected by subtraction of a spectrum recorded at the same magnetic field but with no sample present. The MCD spectra were fit to the minimal number of Gaussian peaks using Grams AI 9.1 after converting the spectra to wavenumber units. In the fitting process, a minimal number of Gaussians were fit to achieve a satisfactory composite spectrum. Fitting of the VTVH MCD data was achieved using a Fortran program, VTVH 2.1.1, written by M. Riley.
27
The spin Hamiltonian and additional details of the fitting program have been described previously. 28 The fits were tested for robustness once a complete set of parameters had been obtained. To do this, the initial parameters were set to the best-fit parameters and then all allowed to float. Subsequently, one key parameter such as J, D, Mxy, Mxz, or Myz was chosen, and its initial value was set differently, after which the fit process was repeated. Percent polarization for a given fit was calculated from Mxy, Myz, and Mxz using %Mx = (
. My and Mz were calculated correspondingly. 29 Finally, the VTVH MCD data fitting program used a spin Hamiltonian that included the term H = −2JS1S2. accessed by following the link in the citation at the bottom of the page.
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Protein Crystallization
Prior to crystallization, a 25 mg/mL NmDapE protein sample was incubated with 3 equiv of Zn(II) ions and left on ice for 20 min to equilibrate. Zinc(II)-loaded NmDapE was screened against 300 commercially available conditions (Index HT and PEG/Ion HT from Hampton Research and Wizard TM from Emerald Biosystems) using a Mosquito liquid handling robot with 96 plates. 30 Several crystallization conditions were characterized yielding diffraction quality crystals. All crystals were screened, and data were collected on the best-diffracting crystals, which were grown by the sitting-drop vapor-diffusion method at 16 
Structure Solutions and Refinement
The X-ray data were collected at beamline 19-ID of the Structural Biology Center at the Advanced Photon Source. 31 All data were processed and scaled using HKL3000. 32 Molecular replacement searches were completed with MOLREP within the CCP4 suite using the structure of apo-NmDapE as a template [Protein Data Bank (PDB) entry 1VGY]. 16 The asymmetric unit of [Zn_(NmDapE)] (space group P212121) contains a dimer, while crystals of [ZnZn(NmDapE)] and [ZnZn(NmDapE)] in complex with L-captopril both crystallized in the C2221 space group and contained only one subunit of the dimer in the asymmetric unit. Several rounds of rebuilding and readjusting using COOT 33 and refinement using REFMAC 34 and PHENIX 35 improved the initial models. The final models were refined against 95% of the accessed by following the link in the citation at the bottom of the page.
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reflections within the resolution ranges. The remaining 5% of the reflections, which were randomly selected, were used to monitor Rfree. The final refinement statistics are listed in Table 1 . Analysis and validation of all structures were performed with the aid of PROCHECK 36 and MOLPROBITY. 37 The refinement restraints for the L-captopril structure were created with the assistance of COOT and were generated from SMILE string. 
PDB Coordinates
The atomic coordinates for [Zn_(NmDapE)], [ZnZn(NmDapE)], and [ZnZn(NmDapE)] bound by L-captopril were deposited in the PDB as entries 4O23, 4PPZ, and 4PQA, respectively. Table 2 . The kinetic parameters obtained for Zn(II)-loaded NmDapE are very similar to those previously reported for Zn(II)-loaded HiDapE.
Results
Kinetic Studies of [Zn_(NmDapE)] and [ZnZn-(NmDapE)]
14 Of note is the lack of dependence of Km on the zinc content, while the dizinc forms exhibit almost twice the catalytic efficiency of the monozinc forms. L-Captopril was found to be a competitive inhibitor of [ZnZn(NmDapE)] with a Ki of 2.8 μM, a value similar to that observed for [ZnZn(HiDapE)] (Ki of 1.8 μM). 
EPR Spectra of L-Captopril Bound to [Co_(NmDapE)], [CoCo(NmDapE)], [Co_(HiDapE)], and [CoCo(HiDapE)]
EPR spectra of the resting forms of Co(II)-substituted NmDapE ( Figure 1A) and HiDapE ( Figure 1B) 39 These data indicate a preferred binding site with an MS = ± 3 /2 ground state, suggesting a distorted tetrahedral coordination environment. 14 Upon addition of a second equivalent of Co(II), a poorly resolved and apparent MS = ±½ signal was observed at 13 K (traces C in panels A and B of Figure 1 ). In addition, a very weak but clearly identifiable 59 Co hyperfine pattern with Az = 90 G was observed on the low-field edge of the MS = ±½ signal, centered at g′ = 7.9 (850 G; see, e.g., Figure 1A , trace C), but is not clearly visible at the scale used in panels A and B of Figure 1 . This hyperfine signal could be due to a small amount of an additional MS = ± 3 /2 signal with greal(z) ~ 2.6 or else a very rhombic (E/D ~ 1 /3) MS = ±½ signal with greal(y) ~2.9; the origin of the hyperfine split signal is unclear, but it was completely insensitive to L-captopril and was not considered further. ). These data suggest a weak antiferromagnetic interaction between the Co(II) ions in [CoCo(HiDapE)], such that |J| > hν for some, but not all, of the population of dinuclear centers in the sample, i.e., that there is a distribution of J that includes 0.3 cm −1 . No parallel mode (B0‖B1) EPR signals were observed. permission has been granted for this version to appear in e-Publications@Marquette. American Chemical Society does not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission from American Chemical Society.
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Addition of L-captopril induced differential effects in [CoCo(NmDapE)] and [CoCo(HiDapE)]
Addition of L-captopril to [CoCo(NmDapE)] resulted in the sharp MS =± 3 /2 signal at g′ = 6.5 being essentially extinguished, but no overall signal intensity was lost (Figure 2, traces A and B) . This is consistent with additional coordination to the hitherto four-coordinate Co(II) ion but no mediation of significant (≥0.3 cm −1 ) exchange coupling between the two Co(II) ions. In contrast, the addition of Lcaptopril to [CoCo(HiDapE)] leads to a wholesale loss of ~30% of the EPR intensity, with no detectable change in line shape (Figure 2 , traces C and D), signifying an increase, albeit modest, in the level of exchange coupling between the two Co(II) ions. 
16
MCD Spectra of L-Captopril Bound to [Co_(NmDapE)], [CoCo(NmDapE)], [Co_(HiDapE)], and [CoCo(HiDapE)]
MCD spectra of [CoCo(NmDapE)] and [CoCo(HiDapE)] are nearly identical in shape, band energy, and intensity (Figure 3) . It should be noted that the MCD spectra obtained at ambient temperature in the absence of a glycerol glassing agent have the same bands as the low-temperature spectra; however, they are much less intense and broader. All of the bands display temperature-dependent C-terms arising from the paramagnetic high-spin Co(II) ground states. , where the concentration of active sites was used. In both panels, the blue trace is the experimental spectrum and the red traces are the Gaussians used to fit the spectra. accessed by following the link in the citation at the bottom of the page. 
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VTVH MCD data were collected at 503, 532, and 576 nm on both [CoCo(NmDapE)] and [CoCo(HiDapE)]. These data were used to construct magnetization plots; typical examples are shown in Figures  SI-3 -SI-8 of the Supporting Information. The VTVH MCD data were fit as previously described, 27 which yielded the electronic ground-state parameters for magnetic exchange coupling (J) and axial (D) and rhombic (E) zero-field splitting (ZFS). Typical fits are also shown in Figures SI-3-SI-8 of the Supporting Information. Multiple experiments were run, and average values of these parameters along with the standard deviations are given in Table 3 . Magnetic exchange coupling, if it occurs, will be strongest through monatomic bridges (e.g., μ-1,1 as opposed to μ-1,3) . In none of the fittings of the VTVH data from [CoCo(NmDapE)] or [CoCo(HiDapE)] was the quality of the fit improved (lower value of χ 2 ) by having a nonzero J (positive or negative). This strongly suggests that the bridging oxygen atom is in the form of a μ-aqua as opposed to a μ-hydroxo. Many dicobalt(II) complexes with either a μ-aqua or μ-hydroxo have been studied. 8, [44] [45] [46] Aqua-bridged complexes consistently exhibit a small antiferromagnetic coupling (negative J) or no coupling at all, whereas hydroxo-bridged complexes consistently have a small ferromagnetic (positive J) coupling. In addition to the previously reported dicobalt(II) complexes, three new model complexes that are consistent with this trend are shown in Figures SI-13 and SI-14 of the Supporting Information. The ZFS parameters that were determined in the fitting of the VTVH data from [CoCo-(NmDapE)] and [CoCo(HiDapE)] were also consistent with assignment of the 503 nm band to a six-coordinate Co(II), and the 532 and 576 nm bands to a distorted four-coordinate Co(II). Generally, the axial ZFS parameter, D, is >50 cm −1 for six-coordinate high-spin Co(II) and <10 cm −1 for four-coordinate high-spin Co(II). The addition of 1 equiv (based on the concentration of active sites) of L-captopril to either [CoCo(HiDapE)] or [CoCo-(NmDapE)] has no apparent effect on the MCD spectra. However, addition of 5 equiv of L-captopril causes the green resting enzyme solutions to turn blue ( Figure 3B ). The four-coordinate Co(II) bands shift from 532, 559, and 576 nm in [CoCo(HiDapE)] to 530, 565, and 604 nm, respectively, in the [CoCo(HiDapE)]-L-captopril complex, while the bands for the same species shift from 532, 558, and 576 nm in [CoCo(NmDapE)] to 530, 565, and 604 nm, respectively, in the [CoCoNmDapE]-L-captopril complex. The six-coordinate band at 503 nm splits into two bands at 488 and 505 nm for the [CoCo(HiDapE)]-L-captopril and [CoCo(NmDapE)]-L-cap-topril complexes. There is a small peak at 576 nm in both spectra, which is due to uncomplexed enzyme. In addition to these band shifts, there is a roughly 3-fold decrease in MCD intensity, which is not due to loss of Co(II) from the enzyme caused by L-captopril. Finally, the quality of the optical glasses formed in the presence of L-captopril is not as high as for the resting enzyme alone. The resulting MCD spectra had signal-to-noise ratios considerably lower than those of the MCD spectra obtained for the resting enzymes.
8,42
VTVH MCD data were also collected on the 505, 530, and 604 nm bands in the [CoCo(HiDapE)]-L-captopril complex and only for the 604 nm band in the [CoCo(NmDapE)]-L-captopril complex. Example magnetization plots and fits are shown in Figures SI-9 -SI-12 of the Supporting Information. The χ 2 values for fits of the 505 and 530 nm data are quite high as is the χ 2 value for the 604 nm data for the [CoCo-(NmDapE)]-L-captopril complex. The best fits were obtained with a small negative value for J. In addition, the ZFS parameters for both the six-and four-coordinate sites changed but were still in the ranges expected for the corresponding Co(II) species (Table 3) . accessed by following the link in the citation at the bottom of the page. 
Crystal Structures of [Zn_(NmDapE)], [ZnZn-(NmDapE)], and the L-Captopril-Bound [ZnZn(NmDapE)] Complex
The X-ray crystal structures of [Zn_(NmDapE)] (2.1 Å), [ZnZn(NmDapE)] (2.0 Å), and the [ZnZn-(NmDapE)]-L-captopril complex (1.8 Å) were determined. These three structures along with that of apo-NmDapE, which was previously determined (PDB entry 1VGY), 47 reveal the typical two-domain homodimer structure (either present in the asymmetric unit or generated by the crystallographic 2- For [ZnZn(NmDapE)], the first metal binding site, Zn1, resides in a distorted tetrahedral geometry and is bound by the carboxylate OD1 atom of D101 and OE1 atom of E164 as well as the NE1 atom of H68. The Zn2 metal ion resides in a distorted trigonal bipyramidal geometry and is bound by the NE2 atom of H350, two oxygen atoms, OD2 from D101 and OE2 from E136, and the O1 atom of ethylene glycol. Interestingly, for [Zn_(NmDapE)] a full dimer resides in the asymmetric unit, and Zn(II) binding is different between the two active sites. In one of the active sites, a single Zn(II) ion is bound in the first metal binding site, while in the second active site, two Zn(II) ions are present but with occupancies modeled at 60% for Zn1 and 18% for Zn2. These data suggest that metal binding is not strictly permission has been granted for this version to appear in e-Publications@Marquette. American Chemical Society does not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission from American Chemical Society.
21
sequential for NmDapE, which is different from that observed for HiDapE. The 1.8 Å structure of the [ZnZn(NmDapE)]-L-captopril complex reveals clear electron density corresponding to L-captopril inside the positively charged groove, formed between the catalytic and dimerization domains (Figure 4) . The sulfhydryl group of L-captopril bridges the two active site Zn(II) ions with Zn-S distances of 2.3 Å, displacing the bridging water molecule. The carboxylate of the proline moiety of L-captopril forms a hydrogen bond with N346 (ND2-O3, 3.0 Å) and the amide of G325 (N-O2, 2.9 Å). It also makes a strong hydrogen bond with the hydroxyl of Y198 (OH-O3, 2.5 Å), which reaches over from the second subunit of the dimer. The O1 peptide carbonyl oxygen of L-captopril forms a hydrogen bond with a wellordered water molecule (2.8 Å) that is stabilized by its interaction with R179 (NH2-O, 3.1 Å) and P165 (2.6 Å). Correlation of the ZFS observed by MCD with coordination number was used as a coordination number indicator (termed the CN/ZFS correlation). In the CN/ZFS correlation, four-coordinate Co(II) exhibits ZFS < 13 cm −1 , also observed directly here by EPR; fivecoordinate between 20 and 50 cm −1 ; and six-coordinate above 50 cm −1. 48 The ZFS parameters determined from fits of VTVH data for [CoCoNmDapE] and [CoCoHiDapE] are consistent with four-coordinate and six-coordinate Co(II) centers in the active site. On the basis of previously published magnetic properties of several μ-aqua μ-hydroxo dicobalt(II) model complexes, weak to moderately strong antiferromagnetic coupling would be expected from a single oxygen permission has been granted for this version to appear in e-Publications@Marquette. American Chemical Society does not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission from American Chemical Society.
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atom bridge. 49, 50 Fitting of the VTVH data from [CoCoNmDapE] and [CoCoHiDapE] strongly suggests that the bridging oxygen atom, in the resting enzyme, is due to μ-aqua as opposed to μ-hydroxo moieties. MCD data of the L-captopril complexes are consistent with the thiol of L-captopril bridging the two active site Co(II) ions, producing an antiferromagnetically coupled dicobalt(II) center with an S = 0 ground state. The overall changes strongly suggest that L-captopril displaces the bridging water molecule and binds to both metal ions through a monatomic bridge whose ligand-field strength is less than that of water. These findings are consistent with EPR data for [CoCoHiDapE] bound by L-captopril. Taken together, the optical, magneto-optical, and EPR results are in strong agreement and indicate that L-captopril interacts directly with both metal ions.
Additional structural information was obtained from X-ray crystallography, including the finding that no active site ligands are displaced upon L-captopril binding except for replacement of the water molecule that bridges the two Zn(II) ions in the wild-type enzyme by the L-captopril-derived thiolate sulfur atom. The remainder of the molecular structure of DapE is barely perturbed, but some significant hydrogen bonds to L-captopril that likely identify residues important for substrate and inhibitor recognition and/or binding are formed. The binding of L-captopril to the dinuclear active site of [ZnZn-(NmDapE)] provides the first structural data for an inhibited form of any DapE enzyme, providing a model for inhibitor design as well as enzymesubstrate interactions.
Inspection of the X-ray crystal structures of [Zn_(NmDapE)] and [ZnZn(NmDapE)], combined with surface analysis, reveals a deep groove that extends along the borders of the catalytic and dimerization domains and houses the active site. This well-defined and negatively charged cavity is shaped from the top by strand β17 and α10 and in the middle by the loop connecting these two elements (residues 321-328). The bottom of the cavity is formed by a loop (residues 132-142) connecting β-strands β6 and α5 and a loop (residues 341-355) connecting β18 and β19. Because the substrate has a linear shape, we predict that it binds in an extended conformation, lining up along the groove with the peptide bond positioned right over the active site metals. DapE enzymes have strict specificity for the L,L-isoform of SDAP. 24 This specificity is built into the active site that includes both accessed by following the link in the citation at the bottom of the page. [51] [52] [53] Insight into the role of this cavity comes from the structure of the [ZnZn(NmDapE)]-Lcaptopril complex as several interactions between the inhibitor and residues within this cavity are formed. The L-captopril peptide bond forms a hydrogen bond with a well-ordered water molecule, which is stabilized by R179 and P165. In addition, the carboxyl terminus of the dipeptide is held in position by ionic interactions between N346 and G325. Interestingly, the carboxyl group also forms a hydrogen bond with the hydroxyl moiety of Y198, which resides on the other subunit of the dimer. This interaction is of great interest, because it is the first evidence of a residue from the second subunit interacting with an inhibitor bound to the first subunit. These data suggest a heretofore unknown function for dimer formation of DapE enzymes. Specifically, this indicates that the dimerization domain not only is crucial for dimer formation but also could play an important role in substrate recognition and binding. This is consistent with the findings that dimerization domain deletion mutants of HiDapE are inactive, highlighting the importance of DapE dimer formation. 16 In summary, a major limitation in developing a previously undescribed class of antimicrobials that target DapE enzymes has been the lack of knowledge about binding of the inhibitor to the DapE active site, including potential residues involved in substrate recognition and binding. We have spectroscopically and crystallographically characterized the binding of the competitive inhibitor L-captopril to DapE. The thiol moiety of L-captopril coordinates to both active site metal ions in a μ-thiolate fashion. No other inhibitor-centered ligands interact with the active site metal ions. Analysis of the first X-ray crystal structure of a DapE enzyme bound to an exogenous ligand, the [ZnZn(NmDapE)]-L-captopril complex, allowed for identification of several important active site pocket residues. These include R179, P165, and N346 that form hydrogen bonds to the functional groups of L-captopril. Remarkably, Y198 from one subunit was discovered to be involved in hydrogen bond formation with the L-captopril bound to the active site of the opposite subunit. This unforeseen hydrogen bonding interaction may be critical for catalysis and may also prove to be crucial in the development of novel medicinal chemistry leads. Because accessed by following the link in the citation at the bottom of the page. 
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